Fischer Laurent — SEC Form 4 filings

SEC reporting owner CIK 1379344. 16 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2024-02-14 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Adverum Biotechnologies, Inc. (ADVM)CEO, PRESIDENT AND DIRECTOR, Director82 legs · 128,699 sh · $553,9171 leg · 9,126 sh · $18,25237
Mirum Pharmaceuticals, Inc. (MIRM)Director48
AtaiBeckley Inc. (ATAI)Director24
ATAI Life Sciences N.V. (ATAI)Director22

Form 4 filings — Fischer Laurent

FiledFormIssuerReported transactionsSource
2026-09-114AtaiBeckley Inc. (ATAI)Disposition to issuer (D): 206,000 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 121,968 (derivative)EDGAR
2026-06-174Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 3,772 (derivative) @ $0 · Grant/award (A): 1,980 (derivative) @ $0EDGAR
2026-06-084AtaiBeckley Inc. (ATAI)Grant/award (A): 121,968 (derivative) @ $0EDGAR
2026-06-024Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 3,977 · Option exercise (M): 3,977 (derivative) @ $0EDGAR
2025-12-104Adverum Biotechnologies, Inc. (ADVM)Option exercise (M): 150,000 @ $4.20 · Code (U): 351,513 · Code (U): 25,000 · Grant/award (A): 500,000 @ $0 · Code (U): 522,666 · Disposition to issuer (D): 93,000 (derivative) · +10 moreEDGAR
2025-12-084Adverum Biotechnologies, Inc. (ADVM)Purchase (P): 11,085 @ $4.24 · Purchase (P): 117,614 @ $4.31EDGAR
2025-06-274ATAI Life Sciences N.V. (ATAI)Grant/award (A): 103,000 (derivative) @ $0EDGAR
2025-06-204Adverum Biotechnologies, Inc. (ADVM)Disposition to issuer (D): 120,000 (derivative) @ $0 · Grant/award (A): 120,000 (derivative) @ $0 · Disposition to issuer (D): 68,000 (derivative) @ $0 · Grant/award (A): 68,000 (derivative) @ $0 · Disposition to issuer (D): 45,499 (derivative) @ $0 · Grant/award (A): 45,499 (derivative) @ $0 · +10 moreEDGAR
2025-06-024Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 6,268 (derivative) @ $0 · Grant/award (A): 3,977 (derivative) @ $0EDGAR
2025-05-164Adverum Biotechnologies, Inc. (ADVM)Sale (S): 9,126 @ $2EDGAR
2025-02-274Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 25,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2024-08-064Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2024-06-144ATAI Life Sciences N.V. (ATAI)Grant/award (A): 206,000 (derivative) @ $0EDGAR
2024-06-074Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 8,779 (derivative) @ $0 · Grant/award (A): 5,703 (derivative) @ $0EDGAR
2024-03-124Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 315,000 (derivative) @ $0EDGAR
2024-02-144Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 1,104,200 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1379344 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →